Charles River Laboratories has re-aligned its business, unifying its Research Models and Services (RMS) and Preclinical Services (PCS) businesses as part of an effort to provide clients with seamless and integrated products and services to support drug development programs. James C. Foster, chairman, president and chief executive officer, said, “As our clients continue to transform their business models, we must evolve with them. Unifying these two businesses will improve client access to our e...